Hosted on MSN
Lupin’s latest launch: Liraglutide injection hits the US market - What does it treat?
In a global move, Indian pharmaceutical company, Lupin on Friday has launched a generic diabetes medication in the US market. It has launched Liraglutide Injection, 18 mg/3 mL (6 mg/mL) single-patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results